Literature DB >> 15580487

Pharmacoepidemiology and the "impact factor".

Emilio J Sanz1.   

Abstract

The field of "Pharmacoepidemiology/Drug Utilization" research has been analysed by studying published research articles under the medical subject headings (MeSH terms) "Pharmacoepidemiology", "Drug Utilization" and "Drug Utilization Review". There were 1822 articles published, and stored in Medline, during the 32-month period between 1 January 2001 and 31 August 2003; these papers might represent a field of research, due to the similarity of MeSH terms used for coding and the set of journals in which the articles were published. A total of 457 articles, representing 25% of all articles in the field, were published in 14 different journals, and 50% of all articles (948) were collected in only 64 different journals. The two main journals publishing research in "Pharmacoepidemiology/Drug Utilization" are Pharmacoepidemiol Drug Saf and the Eur J Clin Pharmacol. These two publications are the official journals of the three main societies in the field and are at least partially focused on this subject, with 45.7% of all articles in Pharmacoepidemiol Drug Saf and 11.1% of all articles in Eur J Clin Pharmacol included under the studied MeSH terms; other journals only occasionally publish papers in this line of research. These two journals are the leaders in pharmacoepidemiology and drug utilization research, having impact factors (IFs) in 2002/2003 above (1.955/1.972 for EJCP) and a bit below (1.092/1.257 for PDS) the middle of the ranking of publications, according to the IF, in the "Pharmacology and Pharmacy" list of the Science Citation Index (SCI).

Entities:  

Mesh:

Year:  2004        PMID: 15580487     DOI: 10.1007/s00228-004-0840-2

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Why the impact factor of journals should not be used for evaluating research.

Authors:  P O Seglen
Journal:  BMJ       Date:  1997-02-15

2.  The selection of essential drugs: report of a WHO expert committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1977

3.  Citation analysis as a tool in journal evaluation.

Authors:  E Garfield
Journal:  Science       Date:  1972-11-03       Impact factor: 47.728

4.  The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden.

Authors:  U Bergman; P Elmes; M Halse; T Halvorsen; H Hood; P K Lunde; F Sjöqvist; O L Wade; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

5.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  6 in total
  3 in total

Review 1.  Drug utilization review across jurisdictions--a reality or still a distant dream?

Authors:  Lisa K Pulver; Susan E Tett
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

2.  Fate of the abstracts presented at three Spanish clinical pharmacology congresses and reasons for unpublished research.

Authors:  E Montané; X Vidal
Journal:  Eur J Clin Pharmacol       Date:  2007-02       Impact factor: 2.953

3.  Redefining the pharmacology and pharmacy subject category in the journal citation reports using medical subject headings (MeSH).

Authors:  Fernando Minguet; Teresa M Salgado; Claudio Santopadre; Fernando Fernandez-Llimos
Journal:  Int J Clin Pharm       Date:  2017-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.